look at the spam,has a different company name on the bottom on each one..
Wall Street Equity: Keeping You Informed
Symbol - FROI
Current - .55
Short Target - 1.35+
Long Target - 3.80+
Rating - 10 of 10
In our ongoing quest to uncover interesting investment ideas before anyone else finds them, we found Fero Industries, Inc. (OTCBB: FROI - News). The company?s growth through acquisition strategy employs not only acquiring promising new drugs, but also a world class management team and advisors in place to bring the promising new drugs and products to market. FROI?s first acquisition target is Pyro Pharmaceuticals, Inc., a boutique developmental stage drug pharmaceutical company located in Irvine, CA. Pyro?s focus is on developing a new class of antibiotics to fight drug resistant bacteria, such as MRSA.
Now that the recovery is under way, it seems Wall Street is more interested in the little guys?one-drug biotech stocks that could rally double-digits on a single breakthrough, or up-and-comers that are in a prime position to be bought out by a big pharma powerhouse and see shares soar on a takeover bid. These companies are on the cutting-edge of innovation, researching and developing treatments for everything from Anthrax and Swine Flu to MRSA and cancer?and Wall Street is watching them closely.
Fero?s aggressive synergistic growth through acquisition strategy for 2010 has already begun with initial negotiations, contact, and current due diligence taking place on two private and five public companies. Fero intends to parlay the Pyro acquisition by blending Pyro?s world class management team and future acquisitions to grow the companies both horizontally and vertically. Don?t miss out on this super gem in the making. The stock is currently trading at the $0.60 level and could be poised to explode as future acquisition targets are announced. With world class management and synergistic acquisitions in the pipeline, Fero (FROI.OB) could be just what the doctor ordered for your portfolio in 2010!
Wall Street Equity: Keeping You Informed
News 
Market Data 
Discover 
AI
